Delcath Systems - 2004 News Archive

2004 Archive

01/08/04
Delcath Cancer Treatment Responses to be Reported by NCI at GI Cancers Symposium

01/26/04
NCI Study With Delcath Cancer Technology Reports Significant Anti-Tumor Activity

02/24/04
Expert Panel Recommends Testing Delcath System For Colorectal Cancer Metastatic to the Liver

03/09/04
First Patient Accepted in Delcath Phase III Liver Cancer Study

03/11/04
Delcath Cancer Treatment Given to First Phase III Patient

03/22/04
Delcath Completes $2.8 Million Private Placement

04/07/04
Delcath Cancer Technology Reviewed at Radiology Meeting

04/12/04
DELCATH CEO TO BE INTERVIEWED ON CEOCAST LATER THIS MORNING

04/15/04
Delcath CEO Interviewed on CEOCast

09/21/04
Delcath Reports First Half 2004 Activities

Delcath News

June 13, 2007
Delcath Fulfills Nasdaq Independent Director and Audit Committee Requirements With Addition of Two New Directors

June 5, 2007
Delcath Updates Clinical Trials

June 5, 2007
Jonathan J. Lewis, MD Joins Delcath's Board of Directors

May 30, 2007

Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Center

May 24, 2007

Delcath Systems Names Laura A. Philips to Board of Directors

May 24, 2007

Delcath Systems Adds Two Executives

May 17, 2007

Delcath Systems Announces Presentation of Data at World Conference on Interventional Oncology

May 16, 2007
Delcath Systems Issues CEO Letter to Shareholders

May 10, 2007
DELCATH SYSTEMS FILES FIRST QUARTER 2007 10-Q AND SHELF REGISTRATION

April 17, 2007
Delcath Systems Announces Board Resignations

April 10, 2007
DELCATH SYSTEMS ENTERS MODIFICATION AGREEMENT WITH LADDCAP AND MODIFIES STOCKHOLDER RIGHTS PLAN

Stock Quote

Delcath stock tracker

Most recent trade:$1.22

Today's Change:0.00

(Prices delayed up to 20 minutes.)